Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2008
10/23/2008WO2008125487A1 Diphenyl-dihydro-imidazopyridinones
10/23/2008WO2008125111A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008099081A3 Novel triazabenzo[α]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
10/23/2008WO2008041118A3 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
10/23/2008WO2008032157A3 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
10/23/2008US20080262227 Process for making risperidone and intermediates therefor
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262027 5Z)-2-[(2,6-Dichlorophenyl)amino]-5-{[3-(4-morpholinyl)-6-quinoxalinyl]methylidene}-1,3-thiazol-4(5H)-one; inhibiting hYAK3 proteins; autoimmunity, HIV, cancer, drug-induced anemias, myelodysplastic syndrome, aplastic anemia myelosuppression, cytopenia
10/23/2008US20080262025 Processes for the Preparation of Zolpidem and its Hemitartrate
10/23/2008US20080262021 [4-(8-Benzo[1,3]dioxol-5-yl-imidazo[4,5-c]quinolin-1-yl)-phenyl]-acetonitrile; treatment of chronic myeloic leukemia
10/23/2008US20080262020 6-(2-amino-1,3-thiazol-4-yl)-3-(2,4-dichlorophenyl)-1-methyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; affinity for GABAA-receptor-associated omega modulatory sites
10/23/2008US20080262019 Optical Isomers of (+) and (-)-Trans-2,3,4,4A,5,9B-Hexahydro-2,8-Dimethyl-1H-Pyrido[4,3-B] Indole
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080262004 4-[2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-1H-pyrrolo[2,3-b]pyridine; to treat autoimmune disorders like rheumatoid arthritis, glomerulonephritis, neoplasms; antifibrotic agents
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261975 Including Itk kinase; 1-[2-[4-(3-Dimethylamino-propoxy)-phenyl]-4-methyl-5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-methyl-propan-2-ol; inflammation, immunological and allergic disorders
10/23/2008US20080261972 Cgrp Receptor Antagonists
10/23/2008US20080261969 1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them
10/23/2008US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261921 Fused ring heterocycle kinase modulators
10/23/2008CA2684021A1 A method for the preparation of an enantiomer of a tetracyclic benzazepine
10/23/2008CA2684008A1 Diphenyl-dihydro-imidazopyridinones
10/23/2008CA2683820A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
10/23/2008CA2683784A1 Pyrido[2,3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682932A1 A method for the preparation of an enantiomerically pure benzazepine
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2679071A1 Oxazolidinone antibiotics
10/23/2008CA2679069A1 Oxazolidinone antibiotic derivatives
10/23/2008CA2668305A1 Azaindole derivatives as cftr modulators
10/22/2008EP1982980A1 Crystalline form of risperidone
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1981888A2 Inhibitors of tyrosine kinases and uses thereof
10/22/2008EP1981887A2 Pyrrolo[2,3,b]pyridine derivatives useful as raf kinase inhibitors
10/22/2008EP1981886A1 7h-pyridoý3,4-d¨pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
10/22/2008EP1981885A2 A method of preparing a 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor
10/22/2008EP1981881A1 Tetrahydropyrane antibiotics
10/22/2008EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1866308B1 Preparation of a high purity substituted quinoxaline
10/22/2008EP1697359B1 Muscarinic agonists as therapeutic compounds
10/22/2008EP1685129A4 Oxime substituted imidazo ring compounds
10/22/2008EP1677599A4 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
10/22/2008EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
10/22/2008EP1636228B1 Novel pyridopyrazines and use thereof as kinase modulators
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1549652B1 Fused azole-pyrimidine derivatives
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008CN101291938A Compounds and compositions as protein kinase inhibitors
10/22/2008CN101291933A Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/22/2008CN101291932A Triazolopyridine derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101291654A Polymorph transformation of zolpidem in tablet matrix
10/22/2008CN101289447A Trifluoromethyl substituted perylene bis diimines and preparation method thereof
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN100427486C Novel benzimidazole derivatives
10/21/2008US7439374 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439254 Compounds, compositions, and methods
10/21/2008US7439253 for example: the triethylammonium salt of 5,6-dihydro-6-oxo-N2-phenyl-5(sulfoxy)-4H-4,7-methanopyrazolo[3,4-e][1,3]diazepine-2,8(8H)-dicarboxamide
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics
10/21/2008US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
10/21/2008US7439246 Fused heterocyclic kinase inhibitors
10/21/2008US7439236 Pharmaceutical composition for the treatment of CNS and other disorders
10/21/2008CA2438294C Pyridopyrimidine or naphthyridine derivative
10/21/2008CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
10/19/2008WO2008120808A1 Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same
10/16/2008WO2008124849A2 Pyrrolo-pyridine kinase modulators
10/16/2008WO2008124323A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/16/2008WO2008124209A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008WO2008124153A1 Heteroaryl amide analogues as p2x7 antagonists
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008123800A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles
10/16/2008WO2008123796A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122615A1 [2, 6] naphthyridines useful as protein kinase inhibitors
10/16/2008WO2008122614A1 2, 6-naphthyridine derivatives as protein kinase modulators
10/16/2008WO2008122513A1 Heterocycles as orexin antagonists
10/16/2008WO2008122510A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008WO2008122352A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008WO2008027182A3 Indoloquinoline compounds as calcium channel blockers
10/16/2008WO2007106854A3 Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
10/16/2008US20080255364 Method For The Production A-Chloroalkylpyridyl Ketones And/Or The Hydrochlorides Thereof
10/16/2008US20080255358 imidazopyridine compounds such as 8-{[(2,6-Dimethylphenyl)methyl]oxy}-2,3-dimethyl-6-phenylimidazo[1,2-a]pyridine, used as adenosine triphosphatase inhibitors, for therapy of gastrointestinal disorders
10/16/2008US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp)
10/16/2008US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255186 Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255180 4-Substituted Azaadamantane Derivatives and Methods of Use Thereof
10/16/2008US20080255179 Modulate neuronal nicotinic receptor activity; attention deficit disorder, Parkinson's, Tourette's, schizophrenia, cognitive deficits, dementia; acute pain, post-surgical pain, chronic pain, inflammatory pain; 2-[1-azatricyclo[3.3.1.13,7]dec-4-ylidene]-N-(4-methylphenyl)acetamide
10/16/2008US20080255174 Hydroalcoholic Extract Of Erythrina Mulungu, Pharmaceutical Compositions And Processes For Producing These Substances
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 646